About Bihua Chen
Form D filings for Tiger Biotherapeutics in 2023 list Bihua Chen as director.
Bihua Chen first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Bihua Chen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bihua Chen works with at each company, as listed on that company's latest Form D.
Tiger Biotherapeutics Inc. · Form D, Apr 5, 2023